Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2019-06-18 | 2019-12-19 | 86879 |
TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86884 |
TEVA-METOPROLOL | 50MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86896 |
TEVA-METOPROLOL | 50MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86899 |
TEVA-MODAFINIL | 100MG | TABLET | Resolved | 2019-06-18 | 2019-07-31 | 86902 |
OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2019-06-18 | 2019-08-06 | 86905 |
OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2019-06-18 | 2019-07-16 | 86908 |
TEVA-RISEDRONATE | 5MG | TABLET | Resolved | 2019-06-18 | 2019-07-16 | 86911 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86914 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86917 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86920 |
ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86923 |
ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86927 |
TEVA-LATANOPROST | 0.05MG | SOLUTION | Resolved | 2019-06-18 | 2019-08-06 | 86930 |
TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2019-06-18 | 2019-08-06 | 86933 |
TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2019-06-18 | 2020-05-01 | 86936 |
AMPICILLIN SODIUM FOR INJECTION, USP | 1000MG | POWDER FOR SOLUTION | Resolved | 2019-06-18 | 2019-09-19 | 86939 |
AMPICILLIN SODIUM FOR INJECTION, USP | 2000MG | POWDER FOR SOLUTION | Resolved | 2019-06-18 | 2019-09-19 | 86942 |
TEVA-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86945 |
TEVA-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86948 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |